The stock is in a sustained downtrend, with a 1-year price change of -41.7% and currently trading at 52.3% of its 52-week range (close to the 52-week low of $59.5). This positioning near the low end suggests the market is pricing in significant fundamental deterioration, though it could also represent a value opportunity if the sell-off is overdone. The current price of $62.76 is well below the 52-week high of $120.05, indicating persistent selling pressure. Short-term momentum is sharply negative, with 1-month and 3-month price changes of -18.8% and -19.7%, respectively, accelerating the longer-term downtrend. The stock's relative strength versus the S&P 500 is deeply negative across all timeframes (1-month relative strength of -22.9%), confirming broad-based underperformance. The 52-week low of $59.5 provides immediate support, while resistance lies at the 52-week high of $120.05. A breakdown below $59.5 would signal further downside, while a recovery above recent highs would require a fundamental catalyst. The beta of 0.36 indicates the stock is significantly less volatile than the market, meaning the current decline is driven by company-specific factors rather than broad market moves.

Revenue has been declining, with the most recent quarter (Q3 FY2026) reporting $2.62 billion, down 10.2% year-over-year from $2.92 billion in the prior-year quarter. The multi-quarter trend shows deceleration: Q2 FY2026 revenue was $2.89 billion (down from $3.15 billion a year ago), and Q1 FY2026 revenue was $2.92 billion (down from $2.94 billion). Revenue segments indicate a shift toward cost-reimbursable contracts ($1.52 billion) versus fixed-price ($521 million) and time-and-materials ($584 million), which may pressure margins. The company remains profitable, with net income of $200 million in Q3 FY2026 and a net margin of 7.6%. Gross margin was 51.9%, down from 55.2% in the prior-year quarter, indicating margin compression. Operating margin of 9.8% is stable but below the 10.0% level seen a year ago, suggesting cost pressures. The balance sheet shows a debt-to-equity ratio of 3.73, indicating high leverage, but free cash flow generation remains strong at $933 million TTM. The current ratio of 1.78x provides adequate liquidity, and ROE of 77% is exceptionally high, though partly driven by leverage. The company generated $261 million in operating cash flow in Q3, sufficient to cover capital expenditures of $13 million and dividends of $67 million, with $248 million in free cash flow.